DMAC vs NOW · $157.4M cap vs P/E 69, rev $13.28B
DiaMedica Therapeutics Inc (DMAC) versus ServiceNow Inc (NOW) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
ServiceNow Inc (NOW) is a software - application company listed on US. It is led by Bill McDermott.
DMAC does not have a complete income-statement cache yet.
Latest reported NOW revenue for 2025-12-31 was $13.28B. Net income was $1.75B. Revenue was up 20.9% from 2024-12-31 to 2025-12-31. NOW currently screens at market cap $119.00B and trailing P/E 68.7.
DMAC currently screens at market cap $157.4M. NOW currently screens at market cap $119.00B and trailing P/E 68.7.
Not investment advice. Open the DMAC and NOW stock pages for the full models.
Not investment advice.